Heather DiBenedetto joined Tango Therapeutics as Vice President of Development Operations in July 2020. Heather brings over 20 years of drug development experience primarily focused in oncology to her role. Most recently, Heather served as the Head of Therapeutic Operations at Moderna Therapeutics where she worked across disease areas including immune-oncology, infectious disease, rare disease and cardiovascular. Prior to joining Moderna, Heather held roles at Novartis where she was the Global Head of Clinical Operations for early phase oncology, Millennium Pharmaceuticals (now Takeda) and other biotechnology companies and CROs.
Heather earned her Master of Science in Drug Regulatory Affairs & Health Policy from the Massachusetts College of Pharmacy & Health Sciences and her Bachelor of Arts in Zoology from the University of Vermont. Heather holds a Regulatory Affairs (U.S.) certification.